Abstract

Endemicity mapping is required to determining whether a district requires mass drug administration (MDA). Current guidelines for mapping LF require that two sites be selected per district and within each site a convenience sample of 100 adults be tested for antigenemia or microfilaremia. One or more confirmed positive tests in either site is interpreted as an indicator of potential transmission, prompting MDA at the district-level. While this mapping strategy has worked well in high-prevalence settings, imperfect diagnostics and the transmission potential of a single positive adult have raised concerns about the strategy’s use in low-prevalence settings. In response to these limitations, a statistically rigorous confirmatory mapping strategy was designed as a complement to the current strategy when LF endemicity is uncertain. Under the new strategy, schools are selected by either systematic or cluster sampling, depending on population size, and within each selected school, children 9–14 years are sampled systematically. All selected children are tested and the number of positive results is compared against a critical value to determine, with known probabilities of error, whether the average prevalence of LF infection is likely below a threshold of 2%. This confirmatory mapping strategy was applied to 45 districts in Ethiopia and 10 in Tanzania, where initial mapping results were considered uncertain. In 42 Ethiopian districts, and all 10 of the Tanzanian districts, the number of antigenemic children was below the critical cutoff, suggesting that these districts do not require MDA. Only three Ethiopian districts exceeded the critical cutoff of positive results. Whereas the current World Health Organization guidelines would have recommended MDA in all 55 districts, the present results suggest that only three of these districts requires MDA. By avoiding unnecessary MDA in 52 districts, the confirmatory mapping strategy is estimated to have saved a total of $9,293,219.

Highlights

  • Endemicity mapping is the essential first step for countries striving to eliminate neglected tropical diseases

  • Mapping is used by lymphatic filariasis (LF) elimination programs to determine if mass drug administration (MDA) is required

  • A confirmatory mapping strategy was developed that utilizes probability-based sampling of school attending children to determine if the prevalence of LF antigenemia is below a 2% threshold

Read more

Summary

Introduction

Endemicity mapping is the essential first step for countries striving to eliminate neglected tropical diseases. For lymphatic filariasis (LF), a parasitic disease targeted by the World Health Organization (WHO) for elimination as a public health problem by 2020 [1], endemicity mapping (or ‘mapping’) is conducted at the district level following standard guidelines to determine whether the disease is endemic. In areas where W. bancrofti is possibly endemic, LF mapping is conducted using either an immunochromatographic test (ICT) or filariasis test strip (FTS) to measure filarial antigenaemia [5]. Where Brugia spp. are possibly endemic, mapping requires blood films to detect microfilaremia. According to WHO guidelines, if the prevalence of microfilaremia or antigenaemia is !1% in either of the two sites, the district is classified as endemic and MDA is required [6]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call